Archive

Cinven pumps €100m into struggling Eurovita

Potential capital benefits driving $8.1bn non-life run-off market, PwC says

ESG may contribute to deal volume in 2023, firm predicts

Fitch questions if co-insurance demand will hold up in South Korea

Arrangements transferred interest rate risks amid ultra-low environment

Expect more balance sheet volatility as interest rates rise

Swiss Re says less central bank intervention in markets could mean return to "old regime"

Australian health insurers must make "comprehensive reassessment" of capital requirements

Apra is introducing a new capital framework this July

Italian regulator intervenes in capital crisis at Eurovita - UPDATED

Temporary administrator appointed as capital recovery plan rejected

Abacus Life looks to expand life risk transfers for re/insurers

Leader in US life settlements broadens remit in bid for growth

Insurers "cannot work in silos" on net zero strategy, says Aviva's Ben Carr

The insurer's analytics and capital modelling director explained three key steps for achieving net zero

UK firms survive 2022 stress tests on average, but some dip below 100% solvency

Some 54 life and non-life entities tested their solvency under extreme scenarios

Solvency II ratios unlikely to be boosted by equity markets rise

Symmetric adjustment will come into play, says Jefferies